Profound Medical Corp. (PROF)
NASDAQ: PROF · IEX Real-Time Price · USD
7.37
0.00 (0.00%)
At close: May 2, 2024, 4:00 PM
7.36
-0.01 (-0.14%)
After-hours: May 3, 2024, 4:00 PM EDT

Profound Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current2023202220212020201920182017
Market Capitalization
180181227233404130--
Market Cap Growth
--20.21%-2.53%-42.20%210.90%---
Enterprise Value
166168199182339127-14-5
PE Ratio
-7.23-7.23-18.79-9.78-21.06-8.62--
PS Ratio
33.2233.5146.6243.4470.4440.73--
PB Ratio
7.887.745.993.705.2911.83--
P/FCF Ratio
-10.82-10.82-12.07-13.33-25.01-11.30--
P/OCF Ratio
-10.82-10.82-12.07-13.35-25.01-11.30--
EV/Sales Ratio
30.7530.9740.8933.8759.1839.82-7.20-1.21
EV/EBITDA Ratio
-6.91-6.91-14.82-8.24-21.48-9.291.040.36
EV/EBIT Ratio
-6.67-6.67-13.63-7.73-19.95-8.570.950.34
EV/FCF Ratio
-10.00-10.00-10.59-10.40-21.01-11.041.020.37
Debt / Equity Ratio
0.250.250.160.020.020.760.450.36
Debt / EBITDA Ratio
-0.25-0.25-0.45-0.05-0.08-0.61-0.66-0.31
Debt / FCF Ratio
-0.36-0.36-0.32-0.06-0.08-0.73-0.65-0.32
Quick Ratio
5.265.2612.6317.3718.992.184.241.45
Current Ratio
6.586.5814.8218.5620.332.774.811.66
Asset Turnover
0.140.140.090.070.070.110.07-
Interest Coverage
-412.62-412.62--99.38-7.98-113.42-23.88-14.01
Return on Equity (ROE)
-82.00%-82.00%-26.10%-34.70%-26.70%-96.20%-102.00%-
Return on Assets (ROA)
-62.90%-62.90%-23.40%-32.50%-24.70%-51.50%-55.90%-
Return on Capital (ROIC)
-73.15%-73.15%-53.34%-36.94%-19.05%-58.81%-52.33%-91.40%
Earnings Yield
-13.96%-13.83%-5.32%-10.22%-4.75%-11.59%--
FCF Yield
-9.07%-9.24%-8.28%-7.50%-4.00%-8.85%--
Buyback Yield / Dilution
-2.35%-2.35%-0.51%-5.83%-65.58%---
Total Shareholder Return
-2.35%-2.35%-0.51%-5.83%-65.58%---
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).